- My News
- All News
- Most Popular
TOKYO, March 31, 2020 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced formulation of CHUGAI DIGITAL VISION 2030 for a digital transformation clearly distinct from earlier digitalization efforts.
Rapid advances in IT and digital technology enabled new scientific methods utilizing means including artificial intelligence (AI), real-world data (RWD) and real-world evidence (RWE). Moreover, amid growing measures to contain healthcare costs, there is increasing need for pharmaceutical products with true value for patients. Chugai has formulated CHUGAI DIGITAL VISION 2030 for a digital transformation clearly distinct from earlier digitalization efforts. It aims to realize business transformation by digital technologies and provide society-changing healthcare solution.
“In CHUGAI DIGITAL VISION 2030, Chugai has set its goal for 2030 to transform our business by using digital technologies to make Chugai a top innovator in the provision of society-changing healthcare solutions,” said Satoko Shisai, Chugai’s Vice President, General Manager of Digital & IT Supervisory Division. “Our three basic strategies consisting of; 1) Strengthen digital platform, 2) Optimize all value chains, and 3) Digital transformation for drug discovery and development, aims to accelerate the advancement of society and Chugai by generating innovation focused on novel drugs.”
Please also visit CHUGAI DIGITAL we created today in Chugai’s website (Japanese only).
<Three basic strategies of CHUGAI DIGITAL VISION 2030>
Strengthen digital platforms
We will build the hard and soft digital platform. We aim to establish world-class IT platforms through the integration of internal data and creation of a data analysis platform in cooperation with Roche.
Optimize all value chains
We will use digital technology to dramatically boost the efficiency of each department and function, in particular production and marketing processes. Through comprehensive analysis of customer data, we will also commence development of new solutions to enhance the customer experience.
Digital transformation for drug discovery and development
We will improve our capabilities in AI, digital biomarkers (dBMs) and RWD to achieve Digital transformation for Drug Discovery and Development (DxD3) in a way that only Chugai can, with the aim of achieving true personalized healthcare.
Did you like this article?